Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Tissue sealants: Current status, future potential

Nature Medicine volume 2, pages 637–638 (1996)Cite this article

Fibrin sealant has clot-promoting activity that halts bleeding from injury or during surgery.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Alving, B.M., Weinstein, M.J., Finlayson, J.S., Menitove, J.E. & Fratantoni, J.C. Fibrin sealant: Summary of a conference on characteristics and clinical uses. Transfusion 35, 783–790 (1995).

    Article  CAS  Google Scholar 

  2. Zehnder, J.L. & Leung, L.L.K. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood 76, 2011–2016 (1990).

    CAS  PubMed  Google Scholar 

  3. Nichols, W.L. et al. Antibodies to bovine thrombin and coagulation factor V associated with surgical use of topical thrombin or fibrin “glue”: A frequent finding. Blood 82, 59 (1993).

    Google Scholar 

  4. Rousou, J. et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations: A multi-center study. J. Thorac. Cardiovasc. Surg. 97, 194–203 (1989).

    CAS  PubMed  Google Scholar 

  5. Levitsky, S. Randomised clinical trial of Immuno's fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations: A multicenter study. Fibrin Sealant: Characteristics and Clinical Uses. (abst.) (1994).

  6. Milne, A.A., Murphy, W.G., Reading, S.J. & Ruckley, C.V. Fibrin sealant reduces suture line bleeding during carotid endarterectomy; a randomised trial. Eur. J. Vasc. Endovasc. Surg. 10, 91–94 (1995).

    Article  CAS  Google Scholar 

  7. Jackson, M.R. et al. Randomized blinded comparison of a fibrin-based dressing with a placebo control in a femoral artery injury model. Cambridge Symposia 1, 26 (abst.) (1996).

    Google Scholar 

  8. Engelsen, S.J., Kuntz, G., Homdrum, E.M. & Kühlberger, E. A new approach in the management of intraoperative bleeding: The ready-to-use combination of fibrin sealant with a collagen fleece. Cambridge Symposia 1, 26 (abst.) (1996).

    Google Scholar 

  9. Sierra, D.H., Kloss, J., Prior, J. & Wilson, D. Collagen-fibrinogen composite tissue adhesive. Cambridge Symposia 1, 24 (abst.) (1996).

    Google Scholar 

  10. Woolverton, C.J., Singh, M., Drohan, W.N. & MacPhee, M.J. Long-term antibiotic release from fibrin sealant. Cambridge Symposia 1, 30 (abst.) (1996).

    Google Scholar 

  11. Greisler, H.P. Neovascularization of ePTFE peripheral vascular grafts. Cambridge Symposia 1, 28 (abstr.) (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Walter Reed Army Institute of Research, Washington D.C., 20307

    Mark R. Jackson

Authors
  1. Mark R. Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jackson, M. Tissue sealants: Current status, future potential. Nat Med 2, 637–638 (1996). https://doi.org/10.1038/nm0696-637

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0696-637

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing